Nektar Therapeutics | NKTR - Umsatzkosten





Umsatzkosten Veränderung Datum
Agios Pharmaceuticals USD 1.32M 560K 2026-03
ALKERMES USD 120.7M 47.44M 2026-06
Amgen USD 1.6B 187M 2026-03
Baxter International USD 1.93B 118M 2026-06
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 945.1M 147.6M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Cara Therapeutics USD 0 0 2025-03
Cipla INR 29.71B 3.4B 2026-06
Dr.Reddys Laboratories INR 39.22B 1.52B 2026-06
Eisai JPY 52.02B 931M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Exelixis USD 19.95M 6.53M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
Grifols EUR 1.51B 184.45M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Incyte USD 104.96M 457K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 9.53M 585K 2026-03
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 7.85B 630M 2026-06
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Takeda JPY 517.6B 42.94B 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
Xencor USD 61.66M 50.95M 2025-06